ELECTRA THERAPEUTICS
Electra Therapeutics is a clinical stage biotechnology company developing therapies that target signal regulatory proteins (SIRP) for the treatment of immunological diseases and cancer. Electra currently has one program in clinical development and two additional preclinical programs. The companyโs lead product candidate, ELA026, is a monoclonal antibody that targets SIRP on the cell surface of myeloid and T cells, and depletes pathological immune cells. ELA026 is in clinical development for secondary hemophagocytic lymphohistiocytosis (sHLH), a life-threatening hyperinflammatory condition for which there is no approved treatment.
ELECTRA THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2018-10-12
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.electra-therapeutics.com
Status:
Active
Contact:
1- 888-743-2290
Email Addresses:
[email protected]
Total Funding:
100 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Aerovate Therapeutics
Aerovate Therapeutics is a biotechnology company focused on developing drugs for rare cardiopulmonary disease.
Allyx Therapeutics
Allyx Therapeutics is a clinical-stage biotechnology company that develops therapies designed to reverse neurodegeneration.
Avrobio
Avrobio is a clinical stage company developing step-change cell and gene therapies targeting cancer and rare disease.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Eliem Therapeutics
Eliem Therapeutics is a clinical-stage biotechnology company developing treatments for nervous system disorders.
Headlands Research
Headlands Research is a globally integrated clinical trial site organization with a mission to improve the clinical trials process.
HiberCell
HiberCell is a biotechnology company developing treatments to prevent cancer relapse and metastasis.
Hoth Therapeutics
Hoth Therapeutics is a clinical-stage biopharmaceutical company focused on developing new generation therapies for dermatological disorders.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Karyopharm Therapeutics
Karyopharm Therapeutics is a clinical-stage pharmaceutical company developing drugs for the treatment of cancer and other major diseases.
Lineage Cell Therapeutics
Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cellular therapies to treat unmet medical needs.
AllStripes
AllStripes is a healthcare technology company that accelerates drug development and research for the treatment of rare diseases.
Seismic Therapeutic
Seismic Therapeutic is a biotechnology company advancing machine learning for immunology drug development.
Shoreline Biosciences
Shoreline Biosciences is a biomedical company intended to establish immunotherapies for seriously ill patients.
Spiral Therapeutics
Spiral Therapeutics is a clinical-stage pharmaceutical company delivering therapies for hearing loss.
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
UNITY Biotechnology
Unity Biotechnology designs therapeutics that prevent, halt, and reverse various diseases of aging.
Current Advisors List
Current Employees Featured
Founder
Investors List
Cormorant Asset Management
Cormorant Asset Management investment in Series B - Electra Therapeutics
New Leaf Venture Partners
New Leaf Venture Partners investment in Series B - Electra Therapeutics
Westlake Village BioPartners
Westlake Village BioPartners investment in Series B - Electra Therapeutics
OrbiMed
OrbiMed investment in Series B - Electra Therapeutics
Cowen Healthcare Investments
Cowen Healthcare Investments investment in Series B - Electra Therapeutics
Redmile Group
Redmile Group investment in Series B - Electra Therapeutics
RA Capital Management
RA Capital Management investment in Series B - Electra Therapeutics
Official Site Inspections
http://www.electra-therapeutics.com Semrush global rank: 5.88 M Semrush visits lastest month: 1.41 K
- Host name: 21.90.145.34.bc.googleusercontent.com
- IP address: 34.145.90.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Electra Therapeutics"
ELECTRA Therapeutics
Grounded in science, we explore and validate novel targets with rigor and resolve, paving the way toward breakthrough therapies for immunological diseases and cancer.See details»
Leadership โ ELECTRA Therapeutics
Emi serves as Head of Human Resources at Electra Therapeutics. She oversees all aspects of HR strategy and operations, including organizational and employee development, benefits, โฆSee details»
Electra Therapeutics - Crunchbase Company Profile
Electra Therapeutics is a clinical stage biotechnology company developing therapies for cancer and other immunological diseases.See details»
Electra Therapeutics - LinkedIn
Electra Therapeutics is a clinical stage biotechnology company developing therapies that target signal regulatory proteins (SIRP) for the treatment of immunological diseases and cancer.See details»
Electra Therapeutics - Funding, Financials, Valuation & Investors
Electra Therapeutics is a clinical stage biotechnology company developing therapies for cancer and other immunological diseases.See details»
Electra Therapeutics 2025 Company Profile: Valuation, โฆ
Information on valuation, funding, cap tables, investors, and executives for Electra Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Pipeline โ ELECTRA Therapeutics
All of our programs are first-in-class and internally generated, each representing an opportunity to make a transformational impact across numerous diseases with high unmet need.See details»
Electra Therapeutics Company Profile - Office Locations ... - Craft
Electra Therapeutics is a clinical-stage biotechnology company that specializes in the treatment of cancer and other immunological diseases. It develops therapies that target signal regulatory โฆSee details»
Electra Therapeutics - Org Chart, Teams, Culture & Jobs | The Org
View Electra Therapeutics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
ELECTRA THERAPEUTICS, INC. in South San Francisco, CA - Bizapedia
Mar 11, 2025 Discover Company Info on ELECTRA THERAPEUTICS, INC. in South San Francisco, CA, such as Contacts, Addresses, Reviews, and Registered Agent.See details»
Associate Director, Document Control & Training | Meet Recruitment
Jan 27, 2025 Electra Therapeutics, based in South San Francisco, California, is a clinical stage biotechnology company developing therapies that target signal regulatory proteins (SIRP) for โฆSee details»
Electra Therapeutics, Inc. (Electra Therapeutics, Inc.) - ่ฏ็ฉ็ฎก็บฟ_ไธ โฆ
About Electra Therapeutics Electra Therapeutics is a clinical stage biotechnology company developing therapies against novel targets for immunological diseases and cancer.See details»
Associate Director, CGMP Quality Assurance | Meet Recruitment
Electra Therapeutics, based in South San Francisco, California, is a clinical stage biotechnology company developing therapies that target signal regulatory proteins (SIRP) for the treatment of โฆSee details»
Electra Therapeutics - Overview, News & Similar companies
Dec 11, 2023 View Electra Therapeutics (www.electra-therapeutics.com) location in California, United States , revenue, industry and description. Find related and similar companies as well โฆSee details»
Breaking New Ground in Immunology & Inflammation
Dec 4, 2024 Kathy Dong, PharmD, president and CEO Electra Therapeutics, recently spoke with Damian Doherty, editor-in-chief of Inside Precision Medicine, to discuss clinical trial results for โฆSee details»
Electra Therapeutics to Present at 43rd Annual J.P. Morgan โฆ
Jan 6, 2025 SOUTH SAN FRANCISCO, Calif., January 06, 2025--Electra Therapeutics, a clinical stage biotechnology company developing antibody therapies against novel targets for โฆSee details»
Electra Therapeutics Builds Leadership Team with Appointment of โฆ
Jun 3, 2024 Electra Therapeutics is a clinical stage biotechnology company developing therapies against novel targets for a broad range of immunological diseases and cancer. The โฆSee details»
ELA-026 by Electra Therapeutics for Hemophagocytic โฆ
Dec 30, 2024 ELA-026 is under clinical development by Electra Therapeutics and currently in Phase I for Hemophagocytic Lymphohistiocytosis. According to GlobalData, Phase I drugs for โฆSee details»
Government of Canada welcomes proposal from Electra Battery โฆ
1 day ago In June 2024, Electra Battery Materials Corporation (Electra) received $5 million from Natural Resources Canadaโs Critical Minerals Research Development and Demonstration โฆSee details»
Electra Therapeutics Presents Late-Breaking Clinical Data at โฆ
Jun 16, 2024 Electra Therapeutics is a clinical stage biotechnology company developing therapies against novel targets for immunological diseases and cancer. The companyโs lead โฆSee details»